United States Biotechnology & Medical Research

Impel Neuropharma Inc (IMPL)

Track

Ticker: IMPL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Impel Neuropharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 19 Dec 2023
Value US$4,655,115.68 | Price 410.28 | Shares 354 (+31.6%)
Sale 19 Dec 2023
Value US$2,845,265.29 | Price 65.41 | Shares 59,198 (-24.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-19 2023-12-19 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
354 +31.6%
410.28
US$4,655,116 		354 +31.6% 410.28 US$4,655,116
2023-12-19 2023-12-19 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
59,198 -24.4%
65.41
US$2,845,265 		59,198 -24.4% 65.41 US$2,845,265
2023-12-19 2023-12-18 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
80,780 -28.4%
315.46
US$964,431 		80,780 -28.4% 315.46 US$964,431
2023-12-19 2023-12-18 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
209,029 -8.5%
0.11
US$22,993 		209,029 -8.5% 0.11 US$22,993
2023-12-19 2023-12-15 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
12,066 -3.5%
0.29
US$3,499 		12,066 -3.5% 0.29 US$3,499
2023-12-19 2023-12-15 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
87,934 -3.5%
0.29
US$25,501 		87,934 -3.5% 0.29 US$25,501
2023-05-12 2023-05-11 PrS Proposed sale
Leaman John Harold

Former Officer

Officer
6,944
2.30
US$15,971 		6,944 2.30 US$15,971
2021-11-22 2021-11-19 B Purchase
0.6
NELSON TIMOTHY S
Non-Executive Director
10,000 +inf%
10.76
US$107,554 		10,000 +inf% 10.76 US$107,554
2021-04-29 2021-04-27 B Purchase
1.4
Norwest Venture Partners XIV, LP
Large shareholder
825,000 +36.6%
15.00
US$12,375,000 		825,000 +36.6% 15.00 US$12,375,000
2021-04-29 2021-04-27 B Purchase
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
450,000 +19.5%
15.00
US$6,750,000 		450,000 +19.5% 15.00 US$6,750,000
2021-04-29 2021-04-27 B Purchase
3.5
5AM Ventures V, L.P.
Large shareholder
575,000 +inf%
15.00
US$8,625,000 		575,000 +inf% 15.00 US$8,625,000
Explore more

More insider trading research around Impel Neuropharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America